Acute Haemolytic Crisis
Summary
A haemolytic crisis is rapid destruction of red blood cells (hemolysis), leading to anemia, jaundice (yellowing from bilirubin), and potentially serious complications. Think of red blood cells as having a normal lifespan of about 120 days—in hemolysis, red cells are destroyed prematurely, faster than the bone marrow can replace them, leading to anemia. Hemolysis can be caused by many things: autoimmune (immune system attacks own red cells), mechanical (artificial heart valves, microangiopathy), infections (malaria, certain bacteria), drugs, or inherited conditions (sickle cell disease, G6PD deficiency). The severity ranges from mild (minimal symptoms) to severe (rapid anemia, shock, renal failure). The key to management is recognizing hemolysis (anemia, jaundice, dark urine, sometimes fever), confirming the diagnosis (blood tests showing hemolysis—low hemoglobin, high bilirubin, high LDH, low haptoglobin, reticulocytosis), identifying the cause (autoimmune, mechanical, infection, drug, inherited), and providing appropriate treatment (treat underlying cause, blood transfusion if severe anemia, supportive care). Early recognition and prompt treatment are essential—severe hemolysis can cause rapid anemia, shock, and renal failure.
Key Facts
- Definition: Rapid destruction of red blood cells
- Incidence: Rare to uncommon (varies by cause)
- Mortality: Low (<1%) unless severe and untreated
- Peak age: All ages (varies by cause)
- Critical feature: Anemia, jaundice, signs of hemolysis
- Key investigation: Blood tests (FBC, bilirubin, LDH, haptoglobin, reticulocytes, Coombs test)
- First-line treatment: Treat underlying cause, blood transfusion if severe, supportive care
Clinical Pearls
"Anemia + jaundice = hemolysis until proven otherwise" — If a patient has anemia and jaundice (yellowing), think hemolysis. This is a classic combination.
"LDH up, haptoglobin down = hemolysis" — LDH (lactate dehydrogenase) is elevated in hemolysis. Haptoglobin is low (consumed binding free hemoglobin). This pattern is diagnostic.
"Coombs test tells you if autoimmune" — The Coombs test (direct antiglobulin test) tells you if hemolysis is autoimmune (positive) or not (negative). This guides treatment.
"Treat the cause" — Hemolysis is a symptom, not a disease. Always look for and treat the underlying cause (autoimmune, infection, drug, etc.).
Why This Matters Clinically
Hemolytic crisis can cause rapid anemia, shock, and renal failure if not recognized and treated promptly. Early recognition (especially anemia + jaundice), prompt diagnosis (hemolysis tests), identification of cause, and appropriate treatment are essential. This is a condition that haematologists and emergency clinicians manage, and prompt treatment prevents complications.
Incidence & Prevalence
- Overall: Rare to uncommon (varies by cause)
- Autoimmune: Most common cause (1-3 per 100,000)
- Mechanical: Less common
- Inherited: Varies by condition
- Trend: Stable
Demographics
| Factor | Details |
|---|---|
| Age | All ages (varies by cause) |
| Sex | Varies by cause (autoimmune = slight female) |
| Ethnicity | Some inherited conditions more common in certain populations |
| Geography | Some causes more common in certain areas (malaria, etc.) |
| Setting | Haematology, emergency departments |
Risk Factors
Non-Modifiable:
- Genetics (inherited conditions)
- Age (varies by cause)
Modifiable:
| Risk Factor | Relative Risk | Mechanism |
|---|---|---|
| Drugs | 3-5x | Can cause hemolysis |
| Infections | 3-5x | Can cause hemolysis |
| Autoimmune conditions | 2-3x | Can cause autoimmune hemolysis |
Common Causes
| Cause | Frequency | Typical Patient |
|---|---|---|
| Autoimmune | 40-50% | All ages, female predominance |
| Mechanical | 20-30% | Artificial heart valves, microangiopathy |
| Infections | 10-15% | Malaria, certain bacteria |
| Drugs | 10-15% | Various drugs |
| Inherited | 10-15% | Sickle cell, G6PD deficiency |
| Other | 5-10% | Various |
The Hemolysis Mechanism
Step 1: Red Cell Destruction
- Cause: Autoimmune, mechanical, infection, drug, inherited
- Destruction: Red cells destroyed prematurely
- Result: Hemolysis
Step 2: Anemia
- Rapid loss: Red cells destroyed faster than replaced
- Anemia: Low hemoglobin
- Result: Anemia
Step 3: Bilirubin Release
- Hemoglobin breakdown: Hemoglobin released from destroyed cells
- Bilirubin: Converted to bilirubin
- Jaundice: High bilirubin causes jaundice
- Result: Jaundice
Step 4: Complications
- Severe anemia: Can cause shock
- Renal failure: Hemoglobin can damage kidneys
- Other: Varies by cause
- Result: Complications
Classification by Cause
| Cause | Definition | Clinical Features |
|---|---|---|
| Autoimmune | Immune system attacks own red cells | Coombs positive |
| Mechanical | Physical destruction (valves, microangiopathy) | Coombs negative |
| Infection | Infection destroys red cells | Coombs negative |
| Drug | Drug destroys red cells | Coombs negative or positive |
| Inherited | Genetic condition | Coombs negative |
Anatomical Considerations
Red Cell Destruction:
- Intravascular: Destroyed in blood vessels
- Extravascular: Destroyed in spleen/liver
- Both: Can have both
Why Different Patterns:
- Cause: Determines where destruction happens
- Severity: More severe = more complications
Symptoms: The Patient's Story
Typical Presentation:
History:
Signs: What You See
Vital Signs (May Be Abnormal):
| Sign | Finding | Significance |
|---|---|---|
| Heart rate | May be high (anemia, shock) | Tachycardia |
| Blood pressure | May be low (anemia, shock) | Hypotension, shock |
| Respiratory rate | May be high (anemia) | Tachypnea |
| Temperature | May be elevated (if infection, autoimmune) | Fever |
General Appearance:
Examination Findings:
| Finding | What It Means | Frequency |
|---|---|---|
| Pallor | Anemia | Always |
| Jaundice | High bilirubin | 70-80% |
| Splenomegaly | Extravascular hemolysis | 30-40% |
| Dark urine | Hemoglobinuria (intravascular) | 20-30% (if intravascular) |
Signs of Severe Anemia:
Red Flags
[!CAUTION] Red Flags — Immediate Escalation Required:
- Signs of severe anemia — Needs urgent blood transfusion
- Signs of shock — Medical emergency, needs urgent resuscitation
- Signs of renal failure — Needs urgent assessment, treatment
- Signs of hyperbilirubinemia (jaundice) — Needs assessment
- Rapid progression — Needs urgent assessment
Structured Approach: ABCDE
A - Airway
- Assessment: Usually patent
- Action: Secure if compromised
B - Breathing
- Look: May have respiratory distress (anemia)
- Listen: Usually normal
- Measure: SpO2 (may be low if severe anemia)
- Action: Support if needed
C - Circulation
- Look: Signs of anemia, shock
- Feel: Pulse (may be fast, weak), BP (may be low)
- Listen: Heart sounds (may have flow murmur if anemia)
- Measure: BP (may be low), HR (may be fast)
- Action: Resuscitate if shock
D - Disability
- Assessment: Usually normal (may be altered if severe)
- Action: Assess if severe
E - Exposure
- Look: Full examination, look for jaundice, splenomegaly
- Feel: Spleen, liver
- Action: Complete examination
Specific Examination Findings
Hematological Examination:
- Pallor: Anemia
- Jaundice: Yellow skin/eyes
- Splenomegaly: Extravascular hemolysis
Organ Examination:
- Spleen: May be enlarged
- Liver: Usually normal (may be enlarged if cause)
Special Tests
| Test | Technique | Positive Finding | Clinical Use |
|---|---|---|---|
| FBC | Blood test | Low hemoglobin, high reticulocytes | Anemia, hemolysis |
| Bilirubin | Blood test | Elevated (unconjugated) | Hemolysis |
| LDH | Blood test | Elevated | Hemolysis |
| Haptoglobin | Blood test | Low | Hemolysis |
| Coombs test | Blood test | Positive (if autoimmune) | Autoimmune hemolysis |
First-Line (Bedside) - Do Immediately
1. Clinical Assessment (Most Important)
- History: Anemia, jaundice, triggers
- Examination: Anemia, jaundice, splenomegaly
- Action: High suspicion if anemia + jaundice
2. Blood Tests (Essential)
- FBC: Low hemoglobin, high reticulocytes
- Bilirubin: Elevated (unconjugated)
- LDH: Elevated
- Haptoglobin: Low
- Coombs test: If autoimmune suspected
- Action: Confirms hemolysis, identifies cause
Laboratory Tests
| Test | Expected Finding | Purpose |
|---|---|---|
| Full Blood Count | Low hemoglobin, high reticulocytes | Anemia, hemolysis |
| Bilirubin | Elevated (unconjugated) | Hemolysis |
| LDH | Elevated | Hemolysis |
| Haptoglobin | Low (or absent) | Hemolysis |
| Reticulocytes | Elevated | Bone marrow response |
| Coombs test | May be positive (if autoimmune) | Autoimmune hemolysis |
| Urine | May have hemoglobin (if intravascular) | Intravascular hemolysis |
Imaging
Usually not needed — Clinical assessment and blood tests usually sufficient.
Ultrasound (If Splenomegaly):
| Indication | Finding | Clinical Note |
|---|---|---|
| Splenomegaly | Enlarged spleen | If needed |
Diagnostic Criteria
Clinical Diagnosis:
- Anemia + jaundice + blood tests showing hemolysis = Hemolytic crisis
Hemolysis Tests:
- LDH elevated + haptoglobin low + reticulocytes high = Hemolysis
Cause Classification:
- Coombs positive: Autoimmune
- Coombs negative: Mechanical, infection, drug, inherited
Severity Assessment:
- Mild: Minimal symptoms
- Moderate: Significant anemia, some symptoms
- Severe: Rapid anemia, shock, renal failure
Management Algorithm
SUSPECTED HEMOLYTIC CRISIS
(Anemia + jaundice + signs of hemolysis)
↓
┌─────────────────────────────────────────────────┐
│ CLINICAL ASSESSMENT │
│ • History (anemia, jaundice, triggers) │
│ • Examination (anemia, jaundice, splenomegaly) │
│ • High suspicion if anemia + jaundice │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ BLOOD TESTS (ESSENTIAL) │
│ • FBC (low Hb, high reticulocytes) │
│ • Bilirubin (elevated) │
│ • LDH (elevated) │
│ • Haptoglobin (low) │
│ • Coombs test (if autoimmune suspected) │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ IDENTIFY CAUSE │
├─────────────────────────────────────────────────┤
│ AUTOIMMUNE (Coombs positive) │
│ → Steroids (prednisolone) │
│ → May need other immunosuppressants │
│ │
│ MECHANICAL │
│ → Treat underlying cause (valve, microangiopathy) │
│ │
│ INFECTION │
│ → Treat infection │
│ │
│ DRUG │
│ → Stop drug │
│ │
│ INHERITED │
│ → Supportive care, treat complications │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ TREAT SEVERE ANEMIA (IF NEEDED) │
│ • Blood transfusion (if severe anemia) │
│ • Support circulation │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ SUPPORTIVE CARE │
│ • Monitor for complications (renal failure) │
│ • Folic acid (if needed) │
│ • Monitor recovery │
└─────────────────────────────────────────────────┘
Acute/Emergency Management - The First Hour
Immediate Actions (Do Simultaneously):
-
Clinical Assessment
- History: Anemia, jaundice, triggers
- Examination: Anemia, jaundice, assess severity
- Action: High suspicion if anemia + jaundice
-
Blood Tests (Urgent)
- FBC, bilirubin, LDH, haptoglobin: Confirm hemolysis
- Coombs test: If autoimmune suspected
- Action: Confirms diagnosis, identifies cause
-
Blood Transfusion (If Severe Anemia)
- If severe: Urgent blood transfusion
- Action: Support circulation
-
Identify and Treat Cause
- Autoimmune: Steroids
- Mechanical: Treat underlying cause
- Infection: Treat infection
- Drug: Stop drug
- Inherited: Supportive care
- Action: Address cause
-
Supportive Care
- Monitor: For complications (renal failure)
- Folic acid: If needed
- Action: Support recovery
Medical Management
Autoimmune Hemolysis (If Coombs Positive):
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Prednisolone | 1mg/kg/day (max 60-80mg) | PO | Induction then taper | First-line |
| Rituximab | As appropriate | IV | If steroids fail | Second-line |
| Other immunosuppressants | As appropriate | As needed | If needed | Third-line |
Blood Transfusion (If Severe Anemia):
| Intervention | Details | Notes |
|---|---|---|
| Blood transfusion | If severe anemia | Support circulation |
Supportive Care:
| Intervention | Details | Notes |
|---|---|---|
| Folic acid | If needed | Support bone marrow |
| Monitor renal function | Monitor for renal failure | Prevent complications |
Disposition
Admit to Hospital If:
- Severe anemia: Needs monitoring, transfusion
- Needs treatment: Needs treatment
- Complications: Needs monitoring
Outpatient Management:
- Mild: Can be managed outpatient
- Stable: Can be managed outpatient
Discharge Criteria:
- Stable: No complications
- Treatment started: Treatment initiated
- Clear plan: For continued treatment, follow-up
Follow-Up:
- Regular: Monitor hemoglobin, bilirubin, recovery
- Long-term: Ongoing management (if chronic)
- Treat cause: Address underlying cause
Immediate (Days-Weeks)
| Complication | Incidence | Presentation | Management |
|---|---|---|---|
| Severe anemia | 20-30% | Shock, organ dysfunction | Blood transfusion |
| Renal failure | 10-20% (if intravascular) | Reduced urine output, elevated creatinine | Supportive care, may need dialysis |
| Shock | 10-20% (if severe) | Hypotension, tachycardia | Resuscitation, blood transfusion |
| Death | 1-5% (if severe, not treated) | If not treated | Prevention through early treatment |
Severe Anemia:
- Mechanism: Rapid red cell destruction
- Management: Blood transfusion, treat cause
- Prevention: Early recognition, treatment
Early (Weeks-Months)
1. Usually Improves with Treatment (80-90%)
- Mechanism: Most respond to treatment
- Management: Continue treatment
- Prevention: Early treatment
2. Chronic Hemolysis (10-20%)
- Mechanism: If cause not corrected
- Management: Ongoing management
- Prevention: Address underlying cause
Late (Months-Years)
1. Usually Well Managed (80-90%)
- Mechanism: Most well managed long-term
- Management: Ongoing management
- Prevention: Appropriate treatment
2. Chronic Complications (10-20%)
- Mechanism: If chronic hemolysis
- Management: Ongoing management
- Prevention: Appropriate treatment
Natural History (Without Treatment)
Untreated Hemolytic Crisis:
- Severe anemia: Almost certain if severe
- Shock: High risk if severe
- Poor outcomes: If not treated
Outcomes with Treatment
| Variable | Outcome | Notes |
|---|---|---|
| Recovery | 80-90% | Most recover with treatment |
| Mortality | 1-5% | Lower with treatment |
| Time to recovery | Days to weeks | With treatment |
Factors Affecting Outcomes:
Good Prognosis:
- Early treatment: Better outcomes
- Mild-moderate: Usually recovers quickly
- Treatable cause: Better outcomes
- No complications: Better outcomes
Poor Prognosis:
- Delayed treatment: Higher risk of complications
- Severe hemolysis: Longer recovery
- Untreatable cause: Worse outcomes
- Complications: Worse outcomes
Prognostic Factors
| Factor | Impact on Prognosis | Evidence Level |
|---|---|---|
| Early treatment | Better outcomes | High |
| Severity | More severe = worse | High |
| Cause | Treatable cause = better | Moderate |
| Complications | No complications = better | Moderate |
Key Guidelines
1. BSH Guidelines (2017) — Guidelines for the diagnosis and management of adult autoimmune haemolytic anaemia. British Society for Haematology
Key Recommendations:
- Identify cause
- Treat underlying cause
- Evidence Level: 1A
Landmark Trials
Multiple studies on treatment, outcomes.
Evidence Strength
| Intervention | Level | Key Evidence | Clinical Recommendation |
|---|---|---|---|
| Treat underlying cause | 1A | Multiple studies | Essential |
| Blood transfusion (if severe) | 1A | Multiple studies | Essential |
What is a Hemolytic Crisis?
A hemolytic crisis is when your red blood cells are being destroyed too quickly, faster than your body can replace them. Think of red blood cells as having a normal lifespan—in hemolysis, they're destroyed prematurely, leading to anemia (not enough red cells) and jaundice (yellowing from the breakdown products).
In simple terms: Your red blood cells are being destroyed too quickly. This causes anemia (not enough red cells) and jaundice (yellowing), but with proper treatment, most people recover well.
Why does it matter?
Hemolytic crisis can cause rapid anemia, shock, and renal failure if not recognized and treated promptly. Early recognition and appropriate treatment are essential. The good news? With proper treatment, most people recover well.
Think of it like this: It's like your red blood cells being destroyed too quickly—it needs treatment to stop this and help your body recover, but once treated, most people recover well.
How is it treated?
1. Diagnosis:
- Assessment: Your doctor will assess you and do blood tests
- Tests: You'll have tests to confirm that your red cells are being destroyed and to find the cause
- Why: To confirm the diagnosis and see what's causing it
2. Treat the Cause:
- If autoimmune: You'll get medicines to suppress your immune system (usually steroids)
- If infection: You'll get treatment for the infection
- If drug: You'll stop the drug
- If mechanical: Your doctor will treat the underlying cause (like a heart valve problem)
- If inherited: You'll get supportive care
- Why: To stop the red cell destruction
3. Support Your Body:
- Blood transfusion: If you're very anemic, you'll get a blood transfusion
- Why: To support your body while the cause is treated
- Other support: You may get other supportive care as needed
The goal: Stop the red cell destruction (treat the cause), support your body (blood transfusion if needed), and help you recover.
What to expect
Recovery:
- Treatment: Usually starts immediately
- Recovery: Usually starts improving within days to weeks
- Full recovery: Most people recover well with treatment
After Treatment:
- Medicines: You may need to take medicines (if autoimmune, etc.)
- Monitoring: Your doctor will monitor to make sure you're recovering
- Follow-up: Regular follow-up to monitor your recovery
Recovery Time:
- Acute phase: Usually days to weeks
- Long-term: Depends on cause (may need ongoing treatment if chronic)
When to seek help
Call 999 (or your emergency number) immediately if:
- You feel very weak, dizzy, or faint
- You have severe breathlessness
- You feel very unwell
- You have symptoms that concern you
See your doctor if:
- You have unexplained fatigue or weakness
- You notice your skin or eyes are yellow (jaundice)
- You have dark urine
- You have symptoms that concern you
Remember: If you have unexplained fatigue or weakness, especially if you also have yellowing of your skin or eyes, see your doctor. Hemolytic crisis is serious, but with proper treatment, most people recover well. Don't delay—if you're worried, seek help immediately.
Primary Guidelines
- Hill QA, Stamps R, Massey E, et al. Guidelines on the diagnosis and management of adult autoimmune haemolytic anaemia. Br J Haematol. 2017;176(6):395-411. PMID: 28005290
Key Trials
- Multiple studies on treatment, outcomes.
Further Resources
- BSH Guidelines: British Society for Haematology
Last Reviewed: 2025-12-25 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.